Design of herpesvirus-specific glycosylation inhibitors : R. Datema, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, CT 06492-7660, U.S.A.; S. Olofsson, University of Goteborg, Goteborg, Sweden; D. Shugar, Academy of Sciences, Warsaw, Poland; C. Hirschberg, University of Massachusetts, Worcester, MA, U.S.A.
- 30 April 1990
- journal article
- abstracts
- Published by Elsevier in Antiviral Research
- Vol. 13, 71
- https://doi.org/10.1016/0166-3542(90)90134-s
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: